International Journal of Thin Film Science and Technology
Volume 10
Issue 3 Sep. 2021

Article 5

2021

Studying The Effect of The Dielectric Barrier Discharge Nonthermal Plasma on Colon Cancer Cell line
Abdelmonsef A. Elhadary
Biological Applications Department, EAEA (Egyptian Atomic Energy Authority), Cairo, Egypt,
eng.amira85@yahoo.com

A. El-Zein
Electrical Power &Machines Department Faculty of Engineering, Zagazig University, Zagazig, P.O. 44519,
Egypt, eng.amira85@yahoo.com

M. Talaat
Electrical Power &Machines Department Faculty of Engineering, Zagazig University, Zagazig, P.O. 44519,
Egypt\\ Electrical Department, College of Engineering, Shaqra University, Dawadmi, Al Riyadh, Saudi
Arabia, eng.amira85@yahoo.com

G. El-Aragi
Plasma Physics and Nuclear Fusion Department, EAEA, Cairo, Egypt, eng.amira85@yahoo.com

A. El-Amawy
Electrical Power &Machines Department Faculty of Engineering, Zagazig University, Zagazig, P.O. 44519,
Egypt\\ Plasma Physics and Nuclear Fusion Department, EAEA, Cairo, Egypt, eng.amira85@yahoo.com
Follow this and additional works at: https://digitalcommons.aaru.edu.jo/ijtfst

Recommended Citation
A. Elhadary, Abdelmonsef; El-Zein, A.; Talaat, M.; El-Aragi, G.; and El-Amawy, A. (2021) "Studying The Effect
of The Dielectric Barrier Discharge Non- thermal Plasma on Colon Cancer Cell line," International Journal
of Thin Film Science and Technology: Vol. 10 : Iss. 3 , Article 5.
Available at: https://digitalcommons.aaru.edu.jo/ijtfst/vol10/iss3/5

This Article is brought to you for free and open access by Arab Journals Platform. It has been accepted for
inclusion in International Journal of Thin Film Science and Technology by an authorized editor. The journal is
hosted on Digital Commons, an Elsevier platform. For more information, please contact rakan@aaru.edu.jo,
marah@aaru.edu.jo, u.murad@aaru.edu.jo.

Int. J. Thin.Film. Sci. Tec. 10, No. 3, 161-168 (2021)

161

International Journal of Thin Films Science and Technology

http://dx.doi.org/10.18576/ijtfst/100305

Studying The Effect of The Dielectric Barrier Discharge Nonthermal Plasma on Colon Cancer Cell line
Abdelmonsef A. Elhadary1, A. El-Zein2, M. Talaat2,3, G. El-Aragi4, and A. El-Amawy2,4,*
1

Biological Applications Department, EAEA (Egyptian Atomic Energy Authority), Cairo, Egypt
Electrical Power &Machines Department Faculty of Engineering, Zagazig University, Zagazig, P.O. 44519, Egypt
3
Electrical Department, College of Engineering, Shaqra University, Dawadmi, Al Riyadh, Saudi Arabia
4
Plasma Physics and Nuclear Fusion Department, EAEA, Cairo, Egypt
2

Received: 21 Apr. 2021, Revised: 22 May 2021, Accepted: 24 Jun. 2021.
Published online: 1 Sep. 2021.

Abstract: Non-thermal plasma is a future tool for the treatment of cancer, some diseases, and for many medical
applications. Dielectric Barrier Discharge Plasma (DBDP) is a type of plasma that has been used for the treatment of
cancers in different researches. In this work (DBDP) was used to evaluate its effect on Colon Cancer Cell-line (CaCo Cellline), through three doses depending on the time of exposure (40, 60, and 80 sec.). After exposure, the cell-line were
cultured for 72 hours and followed by two types of analysis. The first was MTT assay for the determination of cell
viability. The second was molecular analysis for two genes associated with cancers; Caspase 9 gene (apoptotic gene) and
Bax gene (pro-apoptotic gene) through detection of their proteins. The results of the study proved that the DBD Plasma has
a strong killing effect on the cancer cell-line (CaCo), and this effect increased with the time of exposure increased. The
study proved also that; the effect of DBDP coming from its effect on the transcription of genes associated with cancer,
where the study found that the degree of transcription of Caspase 9 and Bax genes was significantly increased as the result
of the exposure. Therefore, the results of this study make us consider that DBD Plasma Device is a promised tool for the
treatment of cancer, where the plasma promotes the process of apoptosis in cancer cells.
Keywords: DBD; plasma; CaCo cancer cells; non-thermal plasma, MTT assay, Molecular assay.

1 Introduction
The plasma concept is created by shedding high voltage
energy to the gaseous state that atoms strike together and
diminish their electrons [1]. Plasma has a complicated
structure, It contains a group of electrons, ions, excited and
neutralization atoms, ultraviolet (UV), free radicals,
thermal, infrared radiation, electric fields, and molecules
[2].
Several investigations have proved the antitumor
effectiveness of plasma on various kinds of cancer cells [34].
Over the past decade, cold atmospheric plasma (CAP),
ionized gas near room temperature has a promising
application in cancer therapy. Two devices, dielectric
barrier discharge and plasma jet show a significant anticancer effect on many different cancer cell-lines (in vitro)
and several subcutaneous xenograft tumors (in vivo). In

contrast to conventional anti-cancer approaches and drugs,
cold atmospheric plasma is a selective anti-cancer modality
[5].
In vitro plasma-exposed eukaryotic cells demonstrate
several effects such as cell migration alteration and
apoptosis or necrosis according to cell type and exposure
parameters (power, time of exposure) [6].
Different studies suggested that cancer cells are more
sensitive to cold atmospheric plasma treatment than normal
cells concluding a selective decrease in cancer cell viability
with less cytotoxic effect on nonmalignant cells [7].
Cold atmospheric plasma includes physical effects
(production of ultraviolet, and electromagnetic fields) and
beside chemical components (production of RONS).
Whereas the physical effects seem to have a negligible
cellular impact [8], but RONS may induce cell membrane
alterations, where the increase of the intracellular ROS,
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leads to the decrease of the antioxidant potential and DNA
double-strand brakes and subsequently apoptosis [9].Many
basic cellular responses following cold atmospheric plasma
are( apoptosis, growth inhibition, selective cancer cell
death, cell cycle arrest, DNA and mitochondrial damage,
selective increase of ROS or even immunogenic cell death)
[10].

2 Materials and Methods

The Bax gene translates a protein which upon activation
changes the mitochondria in the cell to motivate cell death
[11].

The electrical circuit of the DBD plasma device consists of
a High Voltage (HV) power supply of voltage up to 15 kV
Alternating Current (AC), a frequency of 50 Hz is
connected to a variable resistance controller to adjust the
input voltage and a charging resistor of 10 kΩ. The input
voltage is connected to the HV electrode (anode) via the
HV probe of attenuation ratio 1000:1 linked to a digital
oscilloscope [16].The biomedical device of the DBD
plasma mainly contains the HVAC power supply, two
electrodes, and a glass dielectric as shown in Fig. 1(a). The
upper electrode is made of iron and the lower electrode
facing the sample is made of iron mesh. They are separated
by 2 mm thick glass.

Upon activation, the Bax gene leads to depolarize the
membrane and to leak the mitochondria to its contents like
cytochrome C [12]. And these lead to changes in the form
or, the structure of the apoptotic cell which is called
morphological differences such as shrinkage and nuclear
condensation, i.e. the shrinkage of the cell and the bleeding
of the membrane, and these changes lead to the release of
vesicles consists of the cellular ingredients which will be
swallow by living cells [13].
The Caspase-9 gene is the fundamental initiator Caspase
that is responsible for the programmed cell death or
mitochondrial apoptosis path [14]. Under exposure to the
apoptosis exciters inside the cell, the cytochrome C is
released by the mitochondria. The activated Caspase-9 can
stimulate the executioner Caspases (Caspase-3, Caspase-6,
and Caspase-7) and release a cascade of steps causing
apoptosis in the cell [15].

2.1 Experimental Setup
The current study was performed in the Biological
applications Department, Plasma and Nuclear Fusion
Department in the Egyptian Atomic Energy Authority.

Fig. 1(b) illustrates the construction of the DBD plasma
apparatus where the diameter of the HV electrode is a 6 cm
iron plate. Plasma is transferred from a source located at a
constant distance of 5 cm up the treated sample; the plasma
is generated as an electrical discharge results from the
electrical breakdown of argon gas in the gap between the
HV electrode and the treated sample.

R= 10 k Ω
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Fig.1(a): the schematic diagram of the biomedical device of the DBD plasma [16].
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Fig.1(b): The DBD plasma photo for biomedical application.
6.
The distance between the sample (cell-line) and the ground
electrode was 5 cm. the gas of plasma was argon, the
atmospheric temperature was 38 oC. The exposure time of
the samples was as the following:
First sample: Control sample, non-exposed.
Second sample: Cell-line exposed for 40 sec.
Third sample: Cell-line exposed for 60 sec.
Fourth sample: Cell-line exposed for 80 sec.
After treatment, each Cell-line sample was divided into 7
portions, and they were cultured for 3 days, then the
determination of the viability of the cell-lines groups for all
samples were obtained by MTT assay.
I. MTT Assay:
Cytotoxicity activity was evaluated for CaCo cells via MTT
3-(4,5-Dimethylthiazol-2yL)-2,5 Diphenyl tetrazolium
bromide) assay (MTT assay kit(cell proliferation) Abcam,
(ab 211391) to Horiuchi et al.,(1988) [17,18] as follow:1.
2.
3.
4.
5.

Cells (1x105 /well) were plated in 0.2 mL of
medium /well in 96-well plates.
Removing medium from the wells carefully after
incubation.
Washing each well with MEM (W/O) FCS 2-3
times and 200µL of MTT (5 mg/ml) was added.
Incubating plates for 6-7 hrs. in 5% CO2 incubator
for cytotoxicity.
Adding 1 mL of DMSO (Solubilizing reagent) was
to each well and mixed well by micro-pipette and
left for 45 sec.

7.

8.

The presence of viable cells was visualized by the
development of purple color due to the formation
of formazan crystals.
Transferring suspension to the cuvette of a
spectrophotometer and the OD (Optical Density)
values were read at 595 nm by using DMSO as a
blank.
Measurements were performed and the
concentration required for a 50% inhibition of
viability (IC50) was determined graphically. The
standard graph was plotted by taking the dose of
treatment on the x-axis and relative cell viability
on the y-axis.
The viability of the cell (%) = x100.

After determination of viability, the cells were going for
another analysis (molecular analysis).
The molecular analysis included proteomics analysis of
caspase-9 and Bax genes.
II. Molecular assay (proteomics analysis):
The proteomics analysis included two genes the caspase-9
gene and the Bax gene
as the following:
Blotting technique:
1- Total soluble proteins for all samples were purified
through tri fast( peq lap VWR company)[isolation of
RNA, DNA, and protein simultaneously]
2- Blotting Solutions:
a- Blotting buffers:
25 mM Tris, pH 7.4, 0.15 M NaCl and 0.1% Tween 20
© 2021 NSP
Natural Sciences Publishing Cor.
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b- Blocking solution:
2-5% nonfat dry milk in Blotting Buffer Adjust pH to 7.4

1-5% nonfat dry milk in Blotting Buffer Adjust pH to 7.4
3. Blotting protocol:
Electrophoresed proteins on SDS-PAGE were transferred to
a Hybond™ nylon membrane (GE Healthcare) via TE62
Standard Transfer Tank with Cooling Chamber (Hoefer
Inc. and incubate for 1 hour at room temperature in
Blocking Solution. Additionally, β-actin was applied as a
housekeeping protein.
4. The membrane was incubated overnight at 4°C in
Antibody Solution containing Anti- Caspase 9 primary
antibody (Abcam, USA, ab25758), and Anti-Bax
(ab232479). For normalizing data, Anti- β-actin primary
antibody (Abcam, ab228001) was used.
5. The membrane was washed at room temperature for 3060 minutes with 5 changes of Blotting Buffer.
6. The membrane was incubated for 1 hour at room
temperature in Antibody Solution containing appropriate
dilution of HRP-conjugated secondary antibody (Antibody
concentration. 0.1-0.5 microgram/mL. Adjust antibody
concentration from 0.05 to 2.0 microgram/mL to obtain
desired signal strength and low background.
7. The membrane was washed for 30-60 minutes with 5
changes of Blotting Buffer.
The technique is called the Western Blot Protocol
References [19, 20, and 21].
Data analysis:

Viability(%)

c- Antibody solution:

100
90
80
70
60
50
40
30
20
10
0
Control

40 sec
60 sec
Groups

80 sec

Fig. 2 Mean value of viability (%) for all groups.
Table 1 and Fig. 2 represent the percent of changes related
to the normal control group. Comparing to the normal
control group, the levels of viability showed a significant
decrease in all treated groups (G2, G3, and G4). At the same
time, the levels of changes were highly significant in G3 and
G4 (60 seconds and 80 seconds of exposure time)
respectively.
i.e. increasing the time of exposure leads to good
treatment.

1. Caspase-9 gene

Gel documentation system (Geldocit, UVP, England) was
applied for data analysis using totallab analysis software,
www.tatallab.com (ver. 1.0.1) [22].

3 Results
3.1 Statistical Analysis
The obtained data were presented as mean ±SE. One-way
analysis of variance (ANOVA) was carried out using a
statical package program (COSTAT). A probability level of
p ˂ 0.05 was considered.
The results of viability were as the following:
Table 1 The mean value of viability (%) for all groups. The
values of G1, G2, G3, and G4 represent the percent of
changes regarding normal control group 1.
Groups

Control
G1 ±SE

40 sec
G2 ±SE

60 sec
G3 ±SE

80 sec
G4 ±SE

Viability

95±1.3(a)

81±2.6(b)

57±2.4(c)

55±2.4(c)

© 2021 NSP
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Fig. 3 The indication level of caspase-9 for CaCo cell line
protein of four treatments.
Table 2: data parameters for the indication level of
caspase-9 of CaCo cell line protein of the four treatments.
Groups

G1
(control)
±SE

G2 ±SE

G3 ±SE

G4 ±SE

Caspase
9

82.5±1.3(
c)

89.91±
2.4(b)

89.91±2.
1(b)

92.72±2.
4(a)
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Fig. 4 Computerized detection of the indication level of
caspase-9 for CaCo cell line protein of four treatments.
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Fig. 7 Computerized detection of the indication level of
Bax protein for CaCo cell line protein of four treatments.
Table 3: data parameters of the indication level of Bax
protein of CaCo cell line protein for the four treatments.
Groups

G1
(control)
±SE

G2 ±SE

G3 ±SE

G4 ±SE

Bax

7.69±0.22
(d)

8.61±0.21
(c)

11.25±0.
30
(b)

12.75±0.41
(a)

14
Fig. 5 the indication level of caspase-9 of CaCo cell line for
four treatments.
1.

Bax gene:

groups of samples

12
10

Bax

8
6
4
2
0
G1(control)

Fig. 6 Bax protein expression level for CaCo cell line
protein of four treatments.

G2

G3

G4

Fig. 8 The indication level of Bax protein of CaCo cell line
for four treatments.
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4 Discussions
Plasma is an ionizing gas that contains charged particles
such as electrons, ions, electronically excited molecules,
and atoms, free radicals, and UV photons. Plasma treating
exposes tissue surface or cells to active long and short-lived
neutral atoms and molecules, including singlet oxygen (O2),
ozone (O3), OH radicals, and NO, and a remarkable flowing
of charged particles, including both positive ions, negative
ions, and electrons [23].
Our physical cells are generated by the mitosis process and
nearly all will stop living or die by the apoptosis process
that is a physiological process of cell to commits suicide.
Cancer happens when this equilibrium is disturbed, either
by the reduction of cell death or the rising in cell
reproduction. The purpose of cancer treatment is to increase
the death of cancer cells without further destruction of the
living cells. [24].

Fig. 9 β-actin protein expression level for CaCo cell line
protein of four treatments.

The results of this study proved that Dielectric barrier
discharge plasma has a strong killing effect on malignant
cells (Table 1 and Fig. 2) where the viability of colon
cancer cells (CaCo) was significantly decreased as the
result of exposure, and increasing the time of exposure
leads to good treatment.
For supporting this result with another analysis (molecular
protein analysis of two genes associated with cancer), and
to know the mechanism of action for DBD plasma on
cancer cells the study proved that; the DBD plasma
exposure induces protein transcription of the Bax gene
(pro-apoptotic gene) as shown in Table 3 and Fig.6 and the
level of transcription increased with increasing time of
exposure.
The same result was found in the case of Caspase 9 gene
transcription (apoptotic gene), where the level of protein
densities was significantly increased as the result of
exposure, and increasing the dose of exposure increase the
level of protein transcription (Table 2 and Fig. 5). This
means that; the plasma induces apoptosis and cell
programmed death of the malignant cells, giving finally
more degradation of cancer cells.

Fig. 10 Computerized detection of β-actin protein
expression level for CaCo cell line protein of four
treatments.
Table 4 data parameters of β-actin protein expression level
for CaCo cell line protein with four treatments.
Groups
β-actin

G1(control)
10.25

© 2021 NSP
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G2
10.37

G3
10.77

G4
10.12

The result of this study is in agreement with many studies
where a significant portion of human breast cancer cells
was observed to exhibit apoptosis fragmentation with the
application of a pulsed atmospheric pressure plasma jet.
The apoptotic effect depends mainly on the components of
the plasma plume [25].
In another study, a comparison of cancerous cells with their
non-cancerous counterparts was performed to determine the
selectivity of treatment. Through analysis of seven human

Int. J. Thin. Fil. Sci. Tec. 10, No. 3, 161-168 (2021) / http://www.naturalspublishing.com/Journals.asp

cell lines (cancerous; A549, U87, A375, and Malme-3M;
non-cancerous: BEAS-2B, HA, and HEMA) and five
different cell culture media (DMEM, PRMI 1640, AM,
BEGM, and DCBM) revealed that the tested parameters
influence indirect cold atmospheric plasma treatment, while
direct treatment was less affected. The study demonstrated
that cell type, cancer type, and culturing medium must be
taking into account [26].
The conclusion of this study stated that Dielectric Barrier
Discharge Plasma has a selectivity degradative effect on
cancer cells through inducing the apoptosis process and
able to destroy cancer cells without any damage to healthy
cells.
In comparison between the densities of resulted protein
(transcription) of the Caspase -nine gene between different
doses of treatment and control group (see Fig. 7 and Table.
2, it was found that group 3 and group 4 (60 seconds and 80
seconds of exposure time) significantly increased which
means that, the DBD plasma increase the transcription level
of Caspase-9 (Apoptotic gene).
Increasing the level of this gene leads to an increase in the
level of degradation of cancer cells.
Regarding the Bax gene, the densities of G3 and G4 (60
seconds and 80 seconds of exposure time) were highly
significant increase in comparison with the control group
(see Fig. 12, Table 3).
This result indicates the same result of the Caspase-nine
gene, and the result of the two genes illustrates that the
exposure time of the cell-line to DBD plasma induces the
transcription of Apoptotic and pro-apoptotic genes which
resulted in a killing effect on malignancy with different
degrees according to the dose of exposure.
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